Profound Medical Statistics Share Statistics Profound Medical has 30.05M
shares outstanding. The number of shares has increased by 22.76%
in one year.
Shares Outstanding 30.05M Shares Change (YoY) 22.76% Shares Change (QoQ) 0.04% Owned by Institutions (%) 39.43% Shares Floating 27.53M Failed to Deliver (FTD) Shares 1,943 FTD / Avg. Volume 1.76%
Short Selling Information The latest short interest is 691.54K, so 2.3% of the outstanding
shares have been sold short.
Short Interest 691.54K Short % of Shares Out 2.3% Short % of Float 2.78% Short Ratio (days to cover) 11.73
Valuation Ratios The PE ratio is -7.02 and the forward
PE ratio is -2.84.
Profound Medical's PEG ratio is
0.34.
PE Ratio -7.02 Forward PE -2.84 PS Ratio 17.41 Forward PS 4.2 PB Ratio 3.08 P/FCF Ratio -7.93 PEG Ratio 0.34
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Profound Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.52,
with a Debt / Equity ratio of 0.08.
Current Ratio 10.52 Quick Ratio 9.64 Debt / Equity 0.08 Debt / EBITDA -0.15 Debt / FCF -0.22 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $75.21K Profits Per Employee $-186.48K Employee Count 142 Asset Turnover 0.15 Inventory Turnover 0.63
Taxes Income Tax -2K Effective Tax Rate -0.01%
Stock Price Statistics The stock price has increased by -34.09% in the
last 52 weeks. The beta is 0.21, so Profound Medical's
price volatility has been higher than the market average.
Beta 0.21 52-Week Price Change -34.09% 50-Day Moving Average 4.92 200-Day Moving Average 5.88 Relative Strength Index (RSI) 62.91 Average Volume (20 Days) 110,553
Income Statement In the last 12 months, Profound Medical had revenue of 10.68M
and earned -26.48M
in profits. Earnings per share was -1.07.
Revenue 10.68M Gross Profit 7.04M Operating Income -33.06M Net Income -26.48M EBITDA -33.06M EBIT -33.06M Earnings Per Share (EPS) -1.07
Full Income Statement Balance Sheet The company has 54.91M in cash and 5.12M in
debt, giving a net cash position of 49.79M.
Cash & Cash Equivalents 54.91M Total Debt 5.12M Net Cash 49.79M Retained Earnings -245.02M Total Assets 49.67M Working Capital 43.09M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -23.45M
and capital expenditures 0, giving a free cash flow of -23.45M.
Operating Cash Flow -23.45M Capital Expenditures n/a Free Cash Flow -23.45M FCF Per Share -0.95
Full Cash Flow Statement Margins Gross margin is 65.89%, with operating and profit margins of -309.57% and -247.94%.
Gross Margin 65.89% Operating Margin -309.57% Pretax Margin 260.47% Profit Margin -247.94% EBITDA Margin -309.57% EBIT Margin -309.57% FCF Margin -219.6%
Dividends & Yields PROF does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PROF is $11,
which is 110.7% higher than the current price. The consensus rating is "Buy".
Price Target $11 Price Target Difference 110.7% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 16, 2019. It was a
backward
split with a ratio of 1:10.
Last Split Date Oct 16, 2019 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -1.79 Piotroski F-Score 3
